We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients who received biologic treatment for asthma did ...

SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

Please provide your email address to receive an email when new articles are posted on . Depemokimab has high binding affinity and potency for IL-5. Eosinophils fell by 83% and 82% with treatment in ...

Dr. Marc Cromie with the Chattanooga Allergy Clinic joins News 12’s Chip Chapman at the start of the New Year with some ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

Patients with severe asthma continue to have residual disease despite initiating treatment with biologics, and severe uncontrolled asthma is associated with higher economic burden compared with ...

Asthma is a very common condition and, while it’s treatable, there’s always a need for new options. Researchers at Trinity College Dublin have now found that an inflammatory “off switch” molecule ...

GSK said Japan's Ministry of Health had approved its bronchial asthma treatment Exdensur after trial results showed ...

GSK’s Exdensur receives Japan’s MHLW approval for severe asthma and chronic rhinosinusitis with nasal polyps: London, UK Wednesday, January 7, 2026, 10:00 Hrs [IST] GSK plc an ...

Treatment with the monoclonal antibody dupilumab led to asthma remission by 24 and 52 weeks in a substantial proportion of patients with uncontrolled moderate-to-severe disease compared with placebo ...

This transcript has been edited for clarity. Michael Wechsler, MD: Hello. I'm Dr Mike Wechsler and welcome to Medscape's InDiscussion series on moderate to severe asthma. This is episode three of the ...

What starts as breathlessness can turn fatal within minutes, doctors warn that quick action, correct inhaler use and timely ...